Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition.

Giordano A, Forte G, Terracciano S, Russo A, Sala M, Scala MC, Johansson C, Oppermann U, Riccio R, Bruno I, Di Micco S.

ACS Med Chem Lett. 2019 Feb 25;10(4):601-605. doi: 10.1021/acsmedchemlett.8b00589. eCollection 2019 Apr 11.

PMID:
30996803
2.

Immunomodulatory Biscembranoids and Assignment of Their Relative and Absolute Configurations: Data Set Modulation in the Density Functional Theory/Nuclear Magnetic Resonance Approach.

Sun P, Cai FY, Lauro G, Tang H, Su L, Wang HL, Li HH, Mándi A, Kurtán T, Riccio R, Bifulco G, Zhang W.

J Nat Prod. 2019 May 24;82(5):1264-1273. doi: 10.1021/acs.jnatprod.8b01037. Epub 2019 Apr 8.

PMID:
30957492
3.

Chemical Proteomics-Guided Identification of a Novel Biological Target of the Bioactive Neolignan Magnolol.

Cassiano C, Esposito R, Tosco A, Casapullo A, Mozzicafreddo M, Tringali C, Riccio R, Monti MC.

Front Chem. 2019 Feb 8;7:53. doi: 10.3389/fchem.2019.00053. eCollection 2019.

4.

Discovery of 3-hydroxy-3-pyrrolin-2-one-based mPGES-1 inhibitors using a multi-step virtual screening protocol.

Lauro G, Cantone V, Potenza M, Fischer K, Koeberle A, Werz O, Riccio R, Bifulco G.

Medchemcomm. 2018 Nov 20;9(12):2028-2036. doi: 10.1039/c8md00497h. eCollection 2018 Dec 1.

PMID:
30746063
5.

Chemoproteomic fishing identifies arzanol as a positive modulator of brain glycogen phosphorylase.

Del Gaudio F, Pollastro F, Mozzicafreddo M, Riccio R, Minassi A, Monti MC.

Chem Commun (Camb). 2018 Nov 13;54(91):12863-12866. doi: 10.1039/c8cc07692h.

PMID:
30375590
6.

Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.

Di Micco S, Pulvirenti L, Bruno I, Terracciano S, Russo A, Vaccaro MC, Ruggiero D, Muccilli V, Cardullo N, Tringali C, Riccio R, Bifulco G.

Bioorg Med Chem. 2018 Aug 7;26(14):3953-3957. doi: 10.1016/j.bmc.2018.06.019. Epub 2018 Jun 20.

PMID:
29934219
7.

Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics.

Terracciano S, Lauro G, Russo A, Vaccaro MC, Vassallo A, De Marco M, Ranieri B, Rosati A, Turco MC, Riccio R, Bifulco G, Bruno I.

Chem Commun (Camb). 2018 Jul 5;54(55):7613-7616. doi: 10.1039/c8cc03399d.

PMID:
29926854
8.

Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening.

Giordano A, Forte G, Massimo L, Riccio R, Bifulco G, Di Micco S.

Eur J Med Chem. 2018 May 25;152:253-263. doi: 10.1016/j.ejmech.2018.04.018. Epub 2018 Apr 12.

PMID:
29730188
9.

Virtual Fragment Screening Identification of a Quinoline-5,8-dicarboxylic Acid Derivative as a Selective JMJD3 Inhibitor.

Giordano A, Del Gaudio F, Johansson C, Riccio R, Oppermann U, Di Micco S.

ChemMedChem. 2018 Jun 20;13(12):1160-1164. doi: 10.1002/cmdc.201800198. Epub 2018 May 22.

10.

Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain.

Terracciano S, Russo A, Chini MG, Vaccaro MC, Potenza M, Vassallo A, Riccio R, Bifulco G, Bruno I.

Sci Rep. 2018 Jan 26;8(1):1709. doi: 10.1038/s41598-017-14902-y.

11.

Discovery of new potent molecular entities able to inhibit mPGES-1.

Di Micco S, Terracciano S, Cantone V, Fischer K, Koeberle A, Foglia A, Riccio R, Werz O, Bruno I, Bifulco G.

Eur J Med Chem. 2018 Jan 1;143:1419-1427. doi: 10.1016/j.ejmech.2017.10.039. Epub 2017 Oct 23.

PMID:
29133047
12.

Identification of Trombospondin-1 as a Novel Amelogenin Interactor by Functional Proteomics.

Capolupo A, Cassiano C, Casapullo A, Andreotti G, Cubellis MV, Riccio A, Riccio R, Monti MC.

Front Chem. 2017 Oct 9;5:74. doi: 10.3389/fchem.2017.00074. eCollection 2017.

13.

Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches.

Morretta E, Esposito R, Festa C, Riccio R, Casapullo A, Monti MC.

Mar Drugs. 2017 Oct 13;15(10). pii: E312. doi: 10.3390/md15100312.

14.

Chemistry and Selective Tumor Cell Growth Inhibitory Activity of Polyketides from the South China Sea Sponge Plakortis sp.

Li J, Li C, Riccio R, Lauro G, Bifulco G, Li TJ, Tang H, Zhuang CL, Ma H, Sun P, Zhang W.

Mar Drugs. 2017 May 3;15(5). pii: E129. doi: 10.3390/md15050129.

15.

Determination of Gymnemic Acid I as a Protein Biosynthesis Inhibitor Using Chemical Proteomics.

Capolupo A, Esposito R, Zampella A, Festa C, Riccio R, Casapullo A, Tosco A, Monti MC.

J Nat Prod. 2017 Apr 28;80(4):909-915. doi: 10.1021/acs.jnatprod.6b00793. Epub 2017 Mar 3.

PMID:
28256837
16.

Bissubvilides A and B, Cembrane-Capnosane Heterodimers from the Soft Coral Sarcophyton subviride.

Sun P, Yu Q, Li J, Riccio R, Lauro G, Bifulco G, Kurtán T, Mándi A, Tang H, Li TJ, Zhuang CL, Gerwick WH, Zhang W.

J Nat Prod. 2016 Oct 28;79(10):2552-2558. Epub 2016 Oct 5.

PMID:
27704808
17.

Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening.

Lauro G, Manfra M, Pedatella S, Fischer K, Cantone V, Terracciano S, Bertamino A, Ostacolo C, Gomez-Monterrey I, De Nisco M, Riccio R, Novellino E, Werz O, Campiglia P, Bifulco G.

Eur J Med Chem. 2017 Jan 5;125:278-287. doi: 10.1016/j.ejmech.2016.09.042. Epub 2016 Sep 14.

PMID:
27688183
18.

Biomolecular proteomics discloses ATP synthase as the main target of the natural glycoside deglucoruscin.

Del Gaudio F, Festa C, Mozzicafreddo M, Vasaturo M, Casapullo A, De Marino S, Riccio R, Monti MC.

Mol Biosyst. 2016 Oct 20;12(10):3132-8. doi: 10.1039/c6mb00460a. Epub 2016 Aug 1.

PMID:
27476482
19.

Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme.

Lauro G, Tortorella P, Bertamino A, Ostacolo C, Koeberle A, Fischer K, Bruno I, Terracciano S, Gomez-Monterrey IM, Tauro M, Loiodice F, Novellino E, Riccio R, Werz O, Campiglia P, Bifulco G.

ChemMedChem. 2016 Mar 17;11(6):612-9. doi: 10.1002/cmdc.201500598. Epub 2016 Feb 24.

PMID:
26915684
20.

2,3-Dihydrobenzofuran privileged structures as new bioinspired lead compounds for the design of mPGES-1 inhibitors.

Di Micco S, Spatafora C, Cardullo N, Riccio R, Fischer K, Pergola C, Koeberle A, Werz O, Chalal M, Vervandier-Fasseur D, Tringali C, Bifulco G.

Bioorg Med Chem. 2016 Feb 15;24(4):820-6. doi: 10.1016/j.bmc.2016.01.002. Epub 2016 Jan 4.

PMID:
26777299

Supplemental Content

Loading ...
Support Center